Is the NHS Betraying High-Risk Men? Why Prostate Cancer Screening Just Got a 'No' Despite 12,000 Annual Deaths

NHS为何对高风险男性说不？前列腺癌筛查被拒，每年1.2万人死亡也无动于衷？

news.sky.com

So the NHS says mass prostate cancer screening causes more harm than good. Tell that to the 12,000 men who die from it every year — including Olympic legends, former PMs, and beloved TV icons. This isn't just policy; it's a moral failure.

NHS说大规模前列腺癌筛查弊大于利。那你去跟每年因此去世的1.2万名男性——包括奥运传奇、前首相和家喻户晓的电视名人——说说看。这已不只是政策问题，而是道德失职。

They're offering screening only for BRCA gene carriers? That's like deploying airbags only in luxury cars. What about black men — twice as likely to get and die from this cancer — or those with a family history? 'Evidence gap' is just bureaucracy hiding behind data.

他们只对携带BRCA基因的人提供筛查？这就像只在豪车里装安全气囊。那黑人男性呢——他们患癌和死亡的概率是两倍——还有家族病史的人呢？所谓的‘证据缺口’不过是官僚主义躲在数据背后罢了。

Oncology Resident (肿瘤科住院医生)

As someone on the front lines, I get the outrage. But PSA screening isn't like mammograms. It has an astronomically high false positive rate. We're talking about biopsies, surgeries, and lifelong side effects for men who may never have developed harmful cancer.

作为一线医护人员，我理解这种愤怒。但前列腺特异性抗原（PSA）筛查和乳腺X光检查不一样。它的假阳性率高得离谱。这意味着，许多根本不会发展成致命癌症的男性，却要接受活检、手术，甚至承受终身副作用。

Brother of a Survivor (癌症幸存者的弟弟)

My brother was diagnosed at 48 because he pushed for a PSA test. No family history. Not BRCA+. But he had cancer. Now he’s fine. If screening ‘harms’ people by saving their lives, maybe we need to redefine ‘harm’.

我哥哥48岁时坚持做了PSA检测才确诊。没有家族病史，也不是BRCA+，但他确实得了癌症。现在他康复了。如果‘伤害’一个人的方式是救了他的命，那我们或许该重新定义‘伤害’了。

Health Economist PhD (卫生经济学博士)

Emotionally, I’m with the campaigners. But NSC’s job isn’t to make us feel good — it’s to do cost-benefit analysis. Overdiagnosis leads to overtreatment, which costs the NHS billions and wrecks lives. This isn't heartless; it's rational.

情感上，我支持这些倡议者。但国家筛查委员会的职责不是让我们感觉良好，而是进行成本效益分析。过度诊断会导致过度治疗，耗资数十亿英镑并毁掉人生。这并非冷酷无情，而是理性决策。

Black Men’s Health Advocate (黑人男性健康倡导者)

Let’s be real: a system that ignores black men’s double risk isn’t ‘rational’ — it’s structurally biased. You keep saying ‘not enough evidence.’ But when will you collect data if you won't screen us? It’s a catch-22.

说白了吧：一个忽视黑人男性双倍风险的系统，根本不是‘理性’，而是结构性偏见。你们总说‘证据不足’，可如果不给我们筛查，数据从何而来？这就是个死循环。

Retired NHS Admin (退休 NHS 行政人员)

Been there. Done that. We tried pilot screenings. The follow-up load broke the system. GPs drowned in referrals. MRIs booked out for months. ‘Save lives’ sounds great — until the entire pipeline collapses.

经历过，尝试过。我们搞过试点筛查，后续负担直接压垮系统。全科医生被转诊淹没，MRI排期排到几个月后。‘拯救生命’听起来很美好——直到整个医疗流程崩溃。

Stephen Fry Fan (斯蒂芬·弗雷粉丝)

If Stephen Fry and Chris Hoy can't move the needle, who can? This country listens to its icons. And right now, they’re being ignored.

如果斯蒂芬·弗雷和克里斯·霍伊都无法撼动局面，还有谁可以？这个国家本该倾听它的偶像。而此刻，他们却被无视了。

Prostate Cancer Researcher (前列腺癌研究人员)

Everyone’s missing the point. The TRANSFORM trial combines PSA with 10-minute MRIs. If that works, we’ll have accurate, low-harm screening. Hold your horses — a real solution may be two years away.

大家都搞错了重点。TRANSFORM试验正将PSA检测与10分钟MRI结合。如果成功，我们将拥有准确且低风险的筛查方式。稍安勿躁——真正的解决方案可能两年内就来了。

Data-Driven Skeptic (数据怀疑论者)

Fry and Hoy are heroes, but heroism doesn’t override epidemiology. If PSA screening only extends life by weeks on average, at massive cost and risk, is it worth it? Let’s wait for the data.

弗雷和霍伊是英雄，但英雄主义无法推翻流行病学。如果PSA筛查平均只能延长几周寿命，却要付出巨大成本与风险，那还值得吗？我们不妨等等数据。

Is the NHS Betraying High-Risk Men? Why Prostate Cancer Screening Just Got a 'No' Despite 12,000 Annual Deaths

NHS为何对高风险男性说不？前列腺癌筛查被拒，每年1.2万人死亡也无动于衷？

英国的疫情封锁并非不可避免——而是一场政策失败。我们为何直到现在才明白这一点？

癌症将被终结？mRNA疫苗触发免疫系统‘全面警报’，或实现广谱抗癌